Stay updated on Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page's location information was reorganized to include a top-level Locations section with Barcelona and Navarre, replacing the previous Barcelona and Navarre Locations entries. The revision version updated to v3.3.3 and the HHS Vulnerability Disclosure link was removed.
    Difference
    0.3%
    Check dated 2025-12-22T00:40:11.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-30T16:19:29.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Publications section now states that publications are automatically filled from PubMed and displays revision: v3.3.1. The previous PubMed-origin wording and the older revision (v3.2.0) have been removed.
    Difference
    0.1%
    Check dated 2025-11-23T14:53:25.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The site-wide government funding status notice has been removed. This administrative change does not affect the study details, eligibility criteria, or user actions on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-16T14:31:53.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Results for NCT03222856 have been posted, including efficacy and safety outcomes. The study record now shows updated completion and enrollment dates.
    Difference
    0.4%
    Check dated 2025-11-02T00:52:47.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a prominent operating-status notice and links; v3.1.0 is removed.
    Difference
    2%
    Check dated 2025-10-04T12:33:13.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page.